Page last updated: 2024-11-01

nifedipine and Adrenocortical Carcinoma

nifedipine has been researched along with Adrenocortical Carcinoma in 2 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oki, K1
Plonczynski, MW1
Luis Lam, M1
Gomez-Sanchez, EP1
Gomez-Sanchez, CE1
Williams, TA1
Monticone, S1
Crudo, V1
Warth, R1
Veglio, F1
Mulatero, P1

Other Studies

2 other studies available for nifedipine and Adrenocortical Carcinoma

ArticleYear
Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
    Endocrinology, 2012, Volume: 153, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Calcium; Calcium Channel Blockers;

2012
Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.
    Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Apoptosis; Calcium; Cell Line, Tumo

2012